AB-Cube
Founded in 2006, AB-Cube revolutionised the life sciences and international healthcare industry with a cloud-based vigilance solution for management of adverse events. They offer a wide range of dedicated solutions like pharmacovigilance, medical device safety, nutrivigilance and CosmEthics® for cosmetovigilance.
They have a diverse international client base, consisting of organisations, academia, CROs and pharmaceutical companies, who are proud to collaborate with AB-Cube for their pharmacovigilance needs.
Learn more: www.ab-cube.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
May 28, 2026
CNIL / Official Journal The French Data Protection Authority (CNIL), Having regard to Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General […]
May 28, 2026
CNIL / Official Journal The French Data Protection Authority (CNIL), Having regard to Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General […]
April 30, 2026
Applied Clinical Trials Online Payment experience—including how, when, and with what level of transparency sites are compensated—is rapidly emerging as a defining factor in the success of clinical trials. Once dismissed as a simple operational nuisance, payments are now recognized as a critical component for shaping site relationships and study outcomes. For years, sites had […]